06180632 is referenced by 215 patents and cites 23 patents.

This invention is directed to quinoline/quinoxaline compounds which inhibit platelet-derived growth factor or p56

lck

tyrosine kinase activity, to pharmaceutical compositions comprising these compounds, and to the use of these compounds for treating a patient suffering from or subject to disorders/conditions involving cellular differentiation, proliferation, extracellular matrix production or mediator release and/or T cell activation and proliferation.

Title
Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases
Application Number
9/198718
Publication Number
6180632 (B2)
Application Date
November 24, 1998
Publication Date
January 30, 2001
Inventor
Martin P Maguire
Woburn
MA, US
Alfred P Spada
Lansdale
PA, US
Wei He
Collegeville
PA, US
Michael R Myers
Reading
PA, US
Agent
Irving Newman
US
Assignee
Aventis Pharmaceuticals Products
NJ, US
IPC
A61K 31/498
View Original Source